Corpus Intelligence IC Memo — LIGHTHOUSE CARE CENTER OF CONWAY 2026-04-26 07:38 UTC
IC Memo — LIGHTHOUSE CARE CENTER OF CONWAY
Investment Committee Memorandum | SC | 105 beds | Grade C | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LIGHTHOUSE CARE CENTER OF CONWAY

CCN 424002 | HORRY, SC | 105 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

LIGHTHOUSE CARE CENTER OF CONWAY is a 105-bed suburban community hospital in HORRY, SC with $14.3M in net patient revenue and a -7.2% operating margin. The hospital serves a payer mix of 11.3% Medicare, 1.5% Medicaid, and 87.2% commercial.

Thesis: Undervalued. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.2% to 0.2% (+737bps).

Net Revenue HCRIS$14.3M
Current EBITDA COMPUTED$-1.0M
Operating Margin COMPUTED-7.2%
Occupancy HCRIS58.6%
Revenue / Bed COMPUTED$136K
Net-to-Gross HCRIS28.6%
Distress Probability ML46.2%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
32
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of -7.2% places it below the state median. Among 32 size-comparable peers (52-210 beds), the median margin is 6.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (52-210), prioritizing same-state peers. 32 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LIGHTHOUSE CARE CENTER OF CONW (Target)SC105$14.3M-7.2%
BON SECOURS ST. FRANCIS XAVIERSC186$304.6M12.2%
BEAUFORT MEMORIAL HOSPITALSC167$269.0M-7.3%
MCLEOD LORIS SEACOAST HOSPITALSC155$262.3M10.1%
MUSC HEALTH FLORENCE MEDICAL CSC187$252.9M-6.9%
CONWAY HOSPITALSC171$250.2M-14.7%
PH PATEWOOD HOSPITALSC64$229.8M38.0%
EAST COOPER REGIONAL MEDICAL CSC120$206.1M28.3%
OCONEE MEMORIAL HOSPITALSC131$190.4M5.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$301K+210bp18mo
Cost to Collect4.5%2.5%$286K+200bp12mo
Denial Rate Reduction12.0%6.5%$284K+198bp12mo
A/R Days Reduction5200.0%3800.0%$174K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$301K
Cost to Collect
$286K
Denial Rate Reduction
$284K
A/R Days Reduction
$174K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$-1.0M
+ RCM Uplift+$1.1M
Pro Forma EBITDA$22K
Current Margin-7.2%
Pro Forma Margin0.2%
WC Released (1x)$549K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.6M$3.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.6M$3.6M0.00x-100.0%
Bull Case9.0x11.0x$-1.4M$6.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.4M$6.7M0.00x-100.0%
Bear Case11.0x10.0x$-1.7M$-1.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.7M$-1.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 32 hospitals with 52-210 beds
  • Same-state prioritization (n=33)
  • Comp margins: P25=-8.9% / P50=6.7% / P75=18.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.